Human IL-13 DTSet enzyme-linked immunoassay kit
Specification | 96*5 Test;96T*15 Test |
---|---|
Standard Curve Range | 46.88 pg/ml -3000 pg/ml |
Standard Curve Gradient | 7 Points/3 Folds |
Number of Incubations | 2 |
Sample Volume | 50 μl |
Type | Not Ready-to-Use |
Test Duration | 120min |

pg/ml | O.D. | Average | Corrected | |
---|---|---|---|---|
0.00 | 0.0317 | 0.0282 | 0.0300 | |
46.88 | 0.0643 | 0.0578 | 0.0611 | 0.0311 |
93.75 | 0.1051 | 0.0989 | 0.1020 | 0.0721 |
187.50 | 0.2052 | 0.2097 | 0.2075 | 0.1775 |
375.00 | 0.4650 | 0.4800 | 0.4725 | 0.4426 |
750.00 | 1.1960 | 1.2390 | 1.2175 | 1.1876 |
1500.00 | 2.7440 | 2.9010 | 2.8225 | 2.7926 |
3000.00 | 4.3974 | 4.5247 | 4.4611 | 4.4311 |
Product Features
- Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
- Development protocols are provided to guide further assay optimization
- Assay can be customized to your specific needs
- Economical alternative to complete kits
Kit Content
- Capture Antibody
- Detection Antibody
- Recombinant Standard
- Streptavidin conjugated to horseradish-peroxidase (Streptavidin-HRP)
Other Reagents Required
DTSet Ancillary Reagent Kit (5 plates): containing 96 well microplates, plate sealers, substrate solution, stop solution, plate coating buffer (PBS), wash buffer, and assay buffer.
- 96 well microplates: YOUKE Life, Catalog # DSEP01. Plate Sealers: YOUKE Life, Catalog # DSSF01.
- Coating Buffer: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2-7.4, 0.2 μm fi ltered . YOUKE Life, Catalog # DSCB01.
- Blocking Buffer: YOUKE Life, Catalog # DSBB01.
- Wash Buffer: 0.05% Tween 20 in PBS, pH 7.2-7.4. YOUKE Life, Catalog # DSWB01.
- Assay Buffer: 0.5%BSA,0.05%Tween20,PBS Solution.YOUKE Life, Catalog # DSAB01
- Substrate Solution: Tetramethylbenzidine. YOUKE Life, Catalog # DSTS01.
- Stop Solution: 0.5mol/ml H2SO4. YOUKE Life, Catalog # DSSS01.
Product Data Sheet
Background: IL-13
IL-13 (Interleukin-13) plays a key role in the pathogenesis of allergy, cancer, and tissue fibrosis. It is secreted by several helper T cell subsets, NK cells, mast cells, eosinophils, basophils, and visceral smooth muscle cells. IL-13 suppresses the production of proinflammatory cytokines and other cytotoxic substances by macrophages, fibroblasts, and endothelial cells. It promotes B cell activation, immunoglobulin class switching to IgE, and the upregulation of CD23/Fc epsilon RII. IL-13 signals through a receptor complex containing IL-13 R alpha 1 and IL-4 R alpha. This complex also functions as the type 2 IL-4 receptor. IL-13 R alpha 2 binds IL-13 and prevents IL-13 from signaling through the IL-13 R alpha 1/IL-4 R alpha complex. IL-13-bound IL-13 R alpha 2 can directly promote tumor cell invasiveness and the development of tissue fibrosis.